Pitavastatin von Mukhtar, R.Y.A., Reid, J., Reckless, J.P.D.

Volltext

Optimisation of cholesterol lowering in high-risk patients in primary care by a nurse-led, targeted review clinic von Reckless, J.P.D, Connolly, S, Griffith, K.E, Bowie, I

Volltext

The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change von McQuigg, M, Brown, J.E, Broom, J, Laws, R.A, Reckless, J.P.D, Noble, P.A, Kumar, S, McCombie, E.L, Lean, M.E.J, Lyons, F.G, Frost, G.S, Quinn, M.F, Barth, J.H, Haynes, S.M, Finer, N, Haslam, D.W, Ross, H.M, Hole, D.J, Radziwonik, S

Volltext

150 The costs of Lipid Lowering: What are the problems now? von Reckless, J.P.D.

Volltext

Counterweight - counter-cost, counter-loss von Lean, M.E.J., Reckless, J.P.D., Finer, N., McCombie, L.

Volltext

Tricks and tools for the primary care provider: the counterweight programme: a continuous improvement methodology model of weight management in UK primary care von McQuigg, M, Broom, J.I, Laws, R.A, Reckless, J.P.D, Noble, P.A, Kumar, S, McCombie, E.L, Lean, M.E.J, Lyons, G.F, Frost, G.S, Quinn, M.F, Barth, J.H, Haynes, S.M, Finer, N, Haslam, D.W, Ross, H.H

Volltext

Economic aspects of cardiovascular disease prevention von Reckless, J.P.D.

Volltext

The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes von Lawrence, J.M, Reid, J, Taylor, G.J, Stirling, C, Reckless, J.P.D

Volltext

Economics of intervention on blood cholesterol for coronary heart disease prevention: evidence for cost effectiveness von Reckless, J.P.D.

Volltext

Serum ferritin: A risk factor for coronary heart disease in diabetes? von Lloyd, J., Stirling, C.A., Reckless, J.P.D.

Volltext

Qualitative diabetic lipoprotein change: Post-prandial profile & bezafibrate therapy von Harris, C., Stirling, G., Lloyd, J., Reckless, J.P.D.

Volltext

Dyslipidaemia may contribute to loss of gender protection from coronary heart disease in non-insulin dependent diabetes von Lloyd, J., Stirling, C.A., Denne, J.S., Reckless, J.P.D.

Volltext

110 Elderly patients with hypercholesterolaemia: results with fluvastatin von Lye, M., Valacio, R., Reckless, J.P.D., Ghosh, A.K., Findlay, I.N., Ghosh, M.K., Passmore, P., Fulcher, R.A.

Volltext

Compositional abnormalities in fasting and post-prandial lipoprotein fractions in non-insulin dependent diabetes mellitus (NIDDM) von Harris, C.P.D., Stirling, C., Lloyd, J., Reckless, J.P.D.

Volltext

The physiological hyperlipidaemia of diabetic and normal pregnancy von Sturley, R.H., Stirling, C., Reckless, J.P.D.

Volltext

We-P11:55 Pioglitazone and metformin have favourable effects on PAI-1 in overweight patients with type 2 diabetes von Lawrence, J.M., Reid, J., Taylor, G.J., Stirling, C.A., Reckless, J.P.D.

Volltext

We-W42:6 Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control von Reid, J., Lawrence, J.M., Taylor, G.J., Stirling, C.A., Reckless, J.P.D.

Volltext

Effect of combined insulin/glipizide therapy on HDL-cholesterol in secondary failure type 2 diabetic patients von Simpson, H.C.R., Stirling, C.A., Reckless, J.P.D.

Volltext

Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia von Betteridge, D.J., Durrington, P.N., Fairhurst, G.J., Jackson, G., McEwan, M.S.R., McInnes, G.T., Miller, J.P., Mir, M.A., Reckless, J.P.D., Rees-Jones, D.I., Scarpello, J.H.B., Bard, J.-M., Fruchart, J.-C., Jewitt-Harris, J., Agnew, A.R., Peters, T.K., Pfister, P.

Volltext

Lipid & lipoprotein profiles after myocardial infarction von Stirling, C., Reckless, J.P.D., Campbell, R.R., Ridley, M.R., Thomas, R.D.

Volltext